By Farms.com
Merck Animal Health launches SEQUIVITY with Microsol Diluvac Forte, a revolutionary vaccine for swine health. Powered by RNA Particle Technology and MDF adjuvant, SEQUIVITY offers tailored protection against prevalent swine diseases.
With SEQUIVITY, swine producers gain access to a flexible and rapid vaccination solution. The platform's immuno-precision capabilities enable targeted vaccine production, addressing evolving disease challenges with accuracy.
Dr. Jeremy Maurer, Associate Director of U.S. Livestock Insights and Outcomes for Merck Animal Health, highlights SEQUIVITY’s role in advancing swine health management. Merck's commitment to innovation ensures effective solutions for the evolving needs of swine producers.